TLDR Potassium channel activators like nicotinamide and minoxidil might help treat solid tumors.
The document discussed the pharmacological potential of nicotinamide and minoxidil, both potassium channel activators, in targeting solid tumors. Nicotinamide had shown promising but unconfirmed results as a radiosensitizer in the ARCON therapeutic strategy, which combines accelerated radiotherapy with carbogen breathing and nicotinamide. Minoxidil, although not previously considered by radiotherapists, was suggested to have potential based on recent pathophysiological insights. The authors proposed a new perspective on using these two established molecules to target solid tumors.
January 2023 in “Dermatologic Therapy” The new 5% minoxidil foam is as effective and safe as Rogaine® for treating hair loss in Chinese men.
16 citations,
January 1995 in “Skin Pharmacology and Physiology” SEPA™ enhances the effectiveness of minoxidil in stimulating hair growth, working faster and better than Rogaine® TS, with no significant side effects.
6 citations,
July 2005 in “Farmaco” A quick and simple method was created to identify minoxidil in hair-growth products using micellar electrokinetic capillary chromatography.
1 citations,
May 2014 in “Hair transplant forum international” Rogaine can stop hair loss in women, and other treatments like certain pills, light therapy, and special shampoos may also work.
April 2011 in “The FASEB Journal” Topical Minoxidil is cost-effective for managing baldness but requires continuous use.
January 2011 in “The Internet Journal of Pharmacology” Minoxidil is cost-effective for regrowing hair on the scalp's top but not the front, requiring ongoing use.
